Clinical Trials Directory

Trials / Completed

CompletedNCT03261362

Impact of Branched-chain Amino Acids in the Development of Insulin Resistance

Branched-Chain Amino Acid Dietary Reduction Under Weight Maintainance in Overweight Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
German Diabetes Center · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to clarify the role of the branched-chain amino acids in the development of Insulin resistance in patients with diabetes

Detailed description

The proposed project aims to elucidate the role of the BCAA in the development of insulin resistance and type 2 diabetes. The project tests the hypothesis that a diet induced decrease of BCAAs concentrations alter the metabolic mechanisms involved in the control insulin resistance and diabetes progression. The specific aims are to elucidate the effect of the diet induced decrease of BCAAs concentrations on (I) peripheral and hepatic insulin sensitivity (II) ectopic fat distribution (III) energy metabolism (IV) metabolic and inflammatory status

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBranched-chain amino acids reduced intake

Timeline

Start date
2016-03-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-08-25
Last updated
2023-06-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03261362. Inclusion in this directory is not an endorsement.

Impact of Branched-chain Amino Acids in the Development of Insulin Resistance (NCT03261362) · Clinical Trials Directory